A Double Blind Randomised Placebo-controlled Trial to Assess the Effect of a Single Administration of Ferric Carboxymaltose of 1000 mg Iron on Glucose Homeostasis, in Iron-deficient Non-anaemic Women of Childbearing Age.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms DIAFER
- 24 Mar 2020 Status changed from recruiting to discontinued.
- 30 Sep 2019 Planned End Date changed from 20 Apr 2021 to 30 Jun 2021.
- 30 Sep 2019 Planned primary completion date changed from 12 May 2020 to 20 Dec 2020.